Andrew Routh
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 6
- Molecular Biology top 5%
- RNA and protein synthesis mechanisms 12
- RNA Research and Splicing 12
- RNA modifications and cancer 10
- Virology top 5%
-
- Mosquito-borne diseases and control 9
- Animal Science and Zoology top 5%
- Animal Virus Infections Studies 5
-
- Bacteriophages and microbial interactions 9
-
- Plant Virus Research Studies 9
- Co-authors
- Daniela RhodesSara SandinJohn E. JohnsonJohn van NoortLynda ChapmanElizabeth JaworskiHeinz NeumannRuth Buning
- Journals
- Nucleic Acids Research (7 papers)Proceedings of the National Academy of Sciences (3 papers)PLoS Pathogens (3 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Andrew Routh
49 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Infectious Diseases 697
- Molecular Biology 1.7k
- Virology 100
- Public Health, Environmental and Occupational Health 480
- Animal Science and Zoology 157
Countries citing papers authored by Andrew Routh
This map shows the geographic impact of Andrew Routh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Routh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Routh more than expected).
Fields of papers citing papers by Andrew Routh
This network shows the impact of papers produced by Andrew Routh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Routh. The network helps show where Andrew Routh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Routh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 23 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 20 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 155 | |
| 10 | 2021 | 22 | |
| 11 | 2020 | 50 | |
| 12 | 2020 | 17 | |
| 13 | 2019 | 15 | |
| 14 | 2019 | 19 | |
| 15 | 2019 | 56 | |
| 16 | 2019 | 88 | |
| 17 | 2019 | 17 | |
| 18 | A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infectionbreakdown → | 2016 | 370 |
| 19 | 2015 | 11 | |
| 20 | 2008 | 244 |
About Andrew Routh
Andrew Routh is a scholar working on Infectious Diseases, Virology, Animal Science and Zoology, Molecular Biology and Insect Science, having authored 49 papers that have together received 2.8k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (12 papers), RNA Research and Splicing (12 papers), RNA modifications and cancer (10 papers), Bacteriophages and microbial interactions (9 papers), Mosquito-borne diseases and control (9 papers), Plant Virus Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Animal Virus Infections Studies (5 papers). The work is most often cited by research in Infectious Diseases (697 citations), Molecular Biology (1.7k citations), Virology (100 citations), Public Health, Environmental and Occupational Health (480 citations) and Animal Science and Zoology (157 citations). Andrew Routh has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Daniela Rhodes, Sara Sandin, John E. Johnson, John van Noort, Lynda Chapman, Elizabeth Jaworski, Heinz Neumann, Ruth Buning, Susan M. Hancock and Tom Owen‐Hughes. Their work appears in journals such as Nucleic Acids Research, Proceedings of the National Academy of Sciences, PLoS Pathogens, Journal of Molecular Biology and Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.